查看“ALK 激酶结构域突变”的源代码

<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff; max-width: 1200px; margin: auto;">

    <div style="margin-bottom: 30px; border-bottom: 1.2px solid #e2e8f0; padding-bottom: 25px;">
        <p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;">
            <strong>ALK 激酶结构域突变</strong>（ALK Kinase Domain Mutations）是指在 <strong>[[ALK]]</strong> 阳性 <strong>[[非小细胞肺癌]]</strong>（NSCLC）治疗过程中，肿瘤细胞为了逃避 <strong>[[ALK抑制剂]]</strong>（ALK-TKI）的杀伤，在 ALK 基因的激酶区发生的<strong>[[二次突变]]</strong>。这些突变会导致药物与 <strong>[[ATP结合口袋]]</strong> 的亲和力下降，从而引发<strong>[[获得性耐药]]</strong>。根据发生位置及机制的不同，主要分为<strong>[[守门员突变]]</strong>（如 <strong>[[L1196M]]</strong>）和<strong>[[溶剂前沿突变]]</strong>（如 <strong>[[G1202R]]</strong>）。不同的突变位点对不同代次的 TKI（如<strong>[[阿来替尼]]</strong>、<strong>[[洛拉替尼]]</strong>）敏感性差异巨大，因此，通过 <strong>[[液体活检]]</strong>（如检测 <strong>[[ctDNA]]</strong>）明确具体的突变类型，是制定后续精准治疗方案的基石。
        </p>
    </div>

    <div class="medical-infobox mw-collapsible mw-collapsed" style="width: 100%; max-width: 320px; margin: 0 auto 35px auto; border: 1.2px solid #bae6fd; border-radius: 12px; background-color: #ffffff; box-shadow: 0 8px 20px rgba(0,0,0,0.05); overflow: hidden;">
        
        <div style="padding: 15px; color: #1e40af; background: linear-gradient(135deg, #e0f2fe 0%, #bae6fd 100%); text-align: center; cursor: pointer;">
            <div style="font-size: 1.2em; font-weight: bold; letter-spacing: 1.2px;">ALK Mutations</div>
            <div style="font-size: 0.7em; opacity: 0.85; margin-top: 4px; white-space: nowrap;">Resistance Mechanism (点击展开)</div>
        </div>
        
        <div class="mw-collapsible-content">
            <div style="padding: 25px; text-align: center; background-color: #f8fafc;">
                <div style="display: inline-block; background: #ffffff; border: 1px solid #e2e8f0; border-radius: 12px; padding: 20px; box-shadow: 0 4px 10px rgba(0,0,0,0.04);">
                    [[Image:ALK_kinase_domain_mutation_map.png|100px|ALK 激酶域突变位点分布]]
                </div>
                <div style="font-size: 0.8em; color: #64748b; margin-top: 12px; font-weight: 600;">耐药的“百变面孔”</div>
            </div>

            <table style="width: 100%; border-spacing: 0; border-collapse: collapse; font-size: 0.85em;">
                <tr>
                    <th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0; width: 40%;">相关疾病</th>
                    <td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;"><strong>[[非小细胞肺癌]]</strong> (NSCLC)</td>
                </tr>
                <tr>
                    <th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">发生时机</th>
                    <td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #1e40af;"><strong>[[靶向治疗]]</strong> 耐药后</td>
                </tr>
                <tr>
                    <th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">最难治突变</th>
                    <td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #b91c1c;"><strong>[[G1202R]]</strong> (溶剂前沿)</td>
                </tr>
                <tr>
                    <th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">最常见突变</th>
                    <td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;"><strong>[[L1196M]]</strong>, <strong>[[G1269A]]</strong></td>
                </tr>
                <tr>
                    <th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">检测手段</th>
                    <td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #166534;"><strong>[[NGS]]</strong> (二代测序)</td>
                </tr>
                 <tr>
                    <th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">终结者药物</th>
                    <td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #166534;"><strong>[[洛拉替尼]]</strong> (第三代)</td>
                </tr>
                <tr>
                    <th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569;">特殊现象</th>
                    <td style="padding: 6px 12px; color: #0f172a;"><strong>[[L1198F]]</strong> (复敏一代药)</td>
                </tr>
            </table>
        </div>
    </div>

    <h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">突变全景图谱：位点决定命运</h2>
    
    <p style="margin: 15px 0; text-align: justify;">
        不同的<strong>[[错义突变]]</strong>位点对药物结合口袋的影响不同，直接决定了患者对一代、二代、三代药物的敏感性。
    </p>

    <div style="overflow-x: auto; margin: 30px auto; max-width: 95%;">
        <table style="width: 100%; border-collapse: collapse; border: 1.2px solid #cbd5e1; font-size: 0.9em; text-align: center;">
            <tr style="background-color: #0f172a; color: #ffffff;">
                <th style="padding: 12px; border: 1px solid #cbd5e1; width: 15%;">突变位点</th>
                <th style="padding: 12px; border: 1px solid #cbd5e1; width: 25%;">一代<br><strong>[[克唑替尼]]</strong></th>
                <th style="padding: 12px; border: 1px solid #cbd5e1; width: 25%;">二代<br><strong>[[阿来]]</strong>/<strong>[[塞瑞]]</strong>/<strong>[[布格]]</strong></th>
                <th style="padding: 12px; border: 1px solid #cbd5e1; width: 35%;">三代<br><strong>[[洛拉替尼]]</strong></th>
            </tr>
            <tr style="background-color: #f1f5f9; font-weight: bold; text-align: left;">
                <td colspan="4" style="padding: 8px 12px; border: 1px solid #cbd5e1; color: #475569;">I. 常见耐药突变 (Common)</td>
            </tr>
            <tr>
                <td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;"><strong>[[L1196M]]</strong><br>(守门员)</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #fee2e2; color: #b91c1c;">耐药</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #dcfce7; color: #166534;">敏感</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #dcfce7; color: #166534;">高度敏感</td>
            </tr>
            <tr>
                <td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;"><strong>[[G1269A]]</strong></td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #fee2e2; color: #b91c1c;">耐药</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #dcfce7; color: #166534;">敏感</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #dcfce7; color: #166534;">高度敏感</td>
            </tr>
            <tr>
                <td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;"><strong>[[C1156Y]]</strong></td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #fee2e2; color: #b91c1c;">耐药</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #dcfce7; color: #166534;">部分敏感</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #dcfce7; color: #166534;">高度敏感</td>
            </tr>
            <tr style="background-color: #f1f5f9; font-weight: bold; text-align: left;">
                <td colspan="4" style="padding: 8px 12px; border: 1px solid #cbd5e1; color: #475569;">II. 难治性突变 (Recalcitrant)</td>
            </tr>
            <tr>
                <td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600; color: #b91c1c;"><strong>[[G1202R]]</strong><br>(溶剂前沿)</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #fee2e2; color: #b91c1c;">耐药</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #fee2e2; color: #b91c1c;">耐药<br>(<strong>[[布格替尼]]</strong>除外*)</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #dcfce7; color: #166534;"><strong>唯一敏感</strong></td>
            </tr>
            <tr>
                <td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;"><strong>[[I1171T]]</strong>/N/S</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #fee2e2; color: #b91c1c;">耐药</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #fef9c3; color: #854d0e;">阿来耐药<br>塞瑞/布格敏感</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #dcfce7; color: #166534;">高度敏感</td>
            </tr>
            <tr>
                <td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;"><strong>[[1151Tins]]</strong></td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #fee2e2; color: #b91c1c;">耐药</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #fee2e2; color: #b91c1c;">耐药</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #dcfce7; color: #166534;">敏感</td>
            </tr>
            <tr style="background-color: #f1f5f9; font-weight: bold; text-align: left;">
                <td colspan="4" style="padding: 8px 12px; border: 1px solid #cbd5e1; color: #475569;">III. 特殊突变 (Paradoxical)</td>
            </tr>
            <tr>
                <td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600; color: #1e40af;"><strong>[[L1198F]]</strong></td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #dcfce7; color: #166534;"><strong>复敏!</strong></td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #fee2e2; color: #b91c1c;">耐药 (洛拉耐药)</td>
                <td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #fee2e2; color: #b91c1c;">耐药</td>
            </tr>
        </table>
        <p style="font-size: 0.85em; color: #64748b; margin-top: 8px;">*注：布格替尼对 G1202R 仅有微弱抑制活性，临床上通常首选 <strong>[[洛拉替尼]]</strong>。</p>
    </div>

    <h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">核心机制解析</h2>
    <div style="background-color: #fff5f5; border-left: 5px solid #e11d48; padding: 15px 20px; margin: 20px 0; border-radius: 4px;">
        <h3 style="margin-top: 0; color: #be123c; font-size: 1.1em;">1. 溶剂前沿突变 ([[G1202R]])</h3>
        <p style="margin-bottom: 0; text-align: justify; font-size: 0.95em; color: #334155;">
            G1202R 是 ALK 耐药的“大魔王”，约占二代药物耐药病例的 50%。G1202 位于 ATP 结合口袋的<strong>溶剂暴露区</strong>。突变为<strong>精氨酸</strong>（R）后，由于引入了庞大的侧链和正电荷，产生了巨大的<strong>[[空间位阻]]</strong>和<strong>静电排斥</strong>，导致一代和二代药物完全无法结合。只有<strong>[[洛拉替尼]]</strong>（大环内酰胺结构，分子极小）能钻进这个狭小的空间发挥作用。
        </p>
    </div>

    <ul style="padding-left: 25px; color: #334155;">
        <li style="margin-bottom: 12px;"><strong>2. 守门员突变 ([[L1196M]])：</strong>
            <br>位于结合口袋深处。突变后的<strong>甲硫氨酸</strong>侧链阻挡了一代药物进入，但二代、三代药物可以绕过此位阻。</li>
        <li style="margin-bottom: 12px;"><strong>3. 复合突变 ([[Compound Mutations]])：</strong>
            <br>指在同一个 ALK 等位基因上同时出现两个或更多突变（如 <strong>G1202R + L1196M</strong>）。这是导致<strong>洛拉替尼耐药</strong>的主要原因，目前极为棘手，可能需要第四代药物（如 <strong>[[NVL-655]]</strong>）治疗。</li>
    </ul>

    <div style="font-size: 0.92em; line-height: 1.6; color: #1e293b; margin-top: 50px; border-top: 2px solid #0f172a; padding: 15px 25px; background-color: #f8fafc; border-radius: 0 0 10px 10px;">
        <span style="color: #0f172a; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献与权威点评</span>
        
        <p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;">
            [1] <strong>Gainor JF, et al. (2016).</strong> <em>Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.</em> <strong>[[Cancer Discovery]]</strong>.<br>
            <span style="color: #475569;">[耐药图谱]：里程碑式研究。通过对大量临床样本的分析，绘制了不同 ALK 抑制剂耐药后的突变频率分布图，确立了 <strong>[[G1202R]]</strong> 的核心地位。</span>
        </p>

        <p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;">
            [2] <strong>Shaw AT, et al. (2016).</strong> <em>Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.</em> <strong>[[New England Journal of Medicine]]</strong>.<br>
            <span style="color: #475569;">[神奇案例]：报道了 <strong>[[L1198F]]</strong> 突变导致洛拉替尼耐药，但令人惊讶地恢复了对第一代药物 <strong>[[克唑替尼]]</strong> 的敏感性，揭示了耐药机制的复杂动态。</span>
        </p>

        <p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;">
            [3] <strong>Katayama R, et al. (2012).</strong> <em>Mechanisms of acquired crizotinib resistance in ALK-rearranged lung cancers.</em> <strong>[[Science Translational Medicine]]</strong>.<br>
            <span style="color: #475569;">[基础机制]：详细解析了包括 <strong>[[L1196M]]</strong>, <strong>[[G1269A]]</strong> 在内的多种突变对药物结合口袋的三维结构影响。</span>
        </p>
    </div>

    <div style="margin: 40px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; font-family: 'Helvetica Neue', Arial, sans-serif; font-size: 0.9em;">
        <div style="background-color: #eff6ff; color: #1e40af; padding: 8px 15px; font-weight: bold; text-align: center; border-bottom: 1px solid #dbeafe;">
            ALK突变 · 知识图谱
        </div>
        <table style="width: 100%; border-collapse: collapse; background-color: #ffffff;">
            <tr style="border-bottom: 1px solid #f1f5f9;">
                <td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">突变分类</td>
                <td style="padding: 10px 15px; color: #334155;"><strong>[[守门员突变]]</strong> (L1196M) • <strong>[[溶剂前沿突变]]</strong> (G1202R)</td>
            </tr>
            <tr style="border-bottom: 1px solid #f1f5f9;">
                <td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">克唑替尼耐药</td>
                <td style="padding: 10px 15px; color: #334155;">[[L1196M]] • [[G1269A]] • [[C1156Y]] (可用二代药解决)</td>
            </tr>
            <tr style="border-bottom: 1px solid #f1f5f9;">
                <td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">阿来替尼耐药</td>
                <td style="padding: 10px 15px; color: #334155;"><strong>[[G1202R]]</strong> (需三代) • [[I1171T]] (可用布格替尼)</td>
            </tr>
            <tr>
                <td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">洛拉替尼耐药</td>
                <td style="padding: 10px 15px; color: #334155;"><strong>[[复合突变]]</strong> (如 1202+1196) • [[L1198F]] (回用一代)</td>
            </tr>
        </table>
    </div>

</div>